114 related articles for article (PubMed ID: 8981622)
1. The non-competitive NMDA antagonist MK-801 increases food intake in rats.
Burns GA; Ritter RC
Pharmacol Biochem Behav; 1997 Jan; 56(1):145-9. PubMed ID: 8981622
[TBL] [Abstract][Full Text] [Related]
2. The NMDA receptor antagonist MK-801 alters lipoprivic eating elicited by 2-mercaptoacetate.
Duva MA; Siu A; Stanley BG
Physiol Behav; 2005 Jan; 83(5):787-91. PubMed ID: 15639164
[TBL] [Abstract][Full Text] [Related]
3. NMDA NR2 receptors participate in CCK-induced reduction of food intake and hindbrain neuronal activation.
Guard DB; Swartz TD; Ritter RC; Burns GA; Covasa M
Brain Res; 2009 Apr; 1266():37-44. PubMed ID: 19232331
[TBL] [Abstract][Full Text] [Related]
4. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
Robinson S; Krentz L; Moore C; Meshul CK
Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor function within the anterior piriform cortex and lateral hypothalamus in rats on the control of intake of amino acid-deficient diets.
Blevins JE; Truong BG; Gietzen DW
Brain Res; 2004 Sep; 1019(1-2):124-33. PubMed ID: 15306246
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
Stuchlík A; Vales K
Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
8. Ingestive effects of NMDA and AMPA-kainate receptor antagonists microinjections into the lateral hypothalamus of the pigeon (Columba livia).
Da Silva AA; Campanella LC; Ramos MC; Faria MS; Paschoalini MA; Marino-Neto J
Brain Res; 2006 Oct; 1115(1):75-82. PubMed ID: 16919612
[TBL] [Abstract][Full Text] [Related]
9. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
[TBL] [Abstract][Full Text] [Related]
10. Delay in meal termination follows blockade of N-methyl-D-aspartate receptors in the dorsal hindbrain.
Treece BR; Covasa M; Ritter RC; Burns GA
Brain Res; 1998 Nov; 810(1-2):34-40. PubMed ID: 9813231
[TBL] [Abstract][Full Text] [Related]
11. MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors.
Ho YJ; Chen KH; Tai MY; Tsai YF
Pharmacol Biochem Behav; 2004 Mar; 77(3):641-6. PubMed ID: 15006477
[TBL] [Abstract][Full Text] [Related]
12. NMDA receptors mediate feeding elicited by neuropeptide Y in the lateral and perifornical hypothalamus.
Lee SW; Stanley BG
Brain Res; 2005 Nov; 1063(1):1-8. PubMed ID: 16259968
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
14. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
Gilbert ME; Lasley SM
Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
[TBL] [Abstract][Full Text] [Related]
15. Noncompetitive NMDA channel blockade during waking intensely stimulates NREM delta.
Campbell IG; Feinberg I
J Pharmacol Exp Ther; 1996 Feb; 276(2):737-42. PubMed ID: 8632344
[TBL] [Abstract][Full Text] [Related]
16. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
17. NMDA antagonist MK-801 does not interfere with the use of spatial representation in a familiar environment.
Uekita T; Okaichi H
Behav Neurosci; 2005 Apr; 119(2):548-56. PubMed ID: 15839801
[TBL] [Abstract][Full Text] [Related]
18. Microinjection of NMDA-type glutamate receptor agonist NMDA and antagonist D-AP-5 into the central nucleus of the amygdale alters water intake rather than food intake.
Yan J; Yan J; Li J; Chen K; Sun H; Zhang Y; Zhao X; Sun B; Zhao S; Song L; Wei X
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):595-600. PubMed ID: 22588904
[TBL] [Abstract][Full Text] [Related]
19. Visceral afferent participation in delayed satiation following NMDA receptor blockade.
Burns GA; Ritter RC
Physiol Behav; 1998 Nov; 65(2):361-6. PubMed ID: 9855488
[TBL] [Abstract][Full Text] [Related]
20. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
